{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-049425","form_type":"8-K/A","ticker":"VIVS","cik":"0001497253","company_name":"VivoSim Labs, INC.","filed_at":"2023-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.091670+00:00","generated_at":"2026-06-10T09:38:47.425340+00:00","sec_items":["2.05","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Organovo cuts 24% of workforce; estimates $0.5M severance costs, $1.5M annual savings","bullets":["Workforce reduction of ~6 employees (24% of staff) effective August 25, 2023.","Estimated $0.5M cash severance through June 30, 2024; annual cost savings of $1.5M.","Former CSO Jeffrey Miner terminated; separation includes $169,250 consulting contract and 40,000 stock options (pending board approval).","Option vesting: 13,000 immediate, 13,500 at 1 year, 13,500 at 2 years."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-049425","json":"https://secwatch.observer/filing/0000950170-23-049425.json","markdown":"https://secwatch.observer/filing/0000950170-23-049425.md","text":"https://secwatch.observer/filing/0000950170-23-049425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023049425/0000950170-23-049425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023049425/onvo-20230816.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:38:47.425340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec2ff6e258","claim":"Jeffrey Miner was terminated as Chief Scientific Officer at VivoSim Labs, INC..","evidence_excerpt":"Jeffrey Miner, Ph.D., the Company’s former Chief Scientific Officer, was notified that his employment with the Company would be terminated. Dr. Miner’s last day of employment was August 25, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023049425/0000950170-23-049425-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"},{"claim_id":"d610280f770c5b72989aee370e95ab1a03d1d6f4","claim":"VivoSim Labs, INC. announced a restructuring with charges of approximately $0.5 million (approximately six employees, which represented approximately 24% of its employees).","evidence_excerpt":"The Company now estimates that it will incur approximately $0.5 million of cash expenditures in connection with the reduction in force, which relate to severance pay, and are expected to be incurred through the quarter ending June 30, 2024.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023049425/0000950170-23-049425-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $0.5 million"},{"label":"Headcount","value":"approximately six employees, which represented approximately 24% of its employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}